Nalaganje...
A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
Neoantigen vaccines have been enthusiastically pursued for personalized cancer immunotherapy while vast majority of neoantigens have no or low immunogenicity. Here, a bi-adjuvant neoantigen nanovaccine (banNV) that codelivered a peptide neoantigen (Adpgk) with two adjuvants [Toll-like receptor (TLR)...
Shranjeno v:
| izdano v: | Sci Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Association for the Advancement of Science
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7080439/ https://ncbi.nlm.nih.gov/pubmed/32206706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aaw6071 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|